Role of vasoactive intestinal peptide in hyperoxia-induced injury of primary type II alveolar epithelial cells

Indian Journal of Pediatrics

Volumn 78, Issue 5, 2011, Pages 535-539

  Ao, Xiaoxiao ^a   Fang, Fang ^a   Xu, Feng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Hyperoxia; Oxidative stress; Type II alveolar epithelial cell; Vasoactive intestinal peptide

Indexed keywords

2',7' DICHLORO DIHYDROTESTOSTERONE FLUORESCEIN DIACETATE; CYCLINE; FLUORESCENT DYE; OXYGEN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DAMAGE; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; EXPOSURE; FLOW CYTOMETRY; HYPEROXIA; LUNG ALVEOLUS CELL TYPE 2; MOLECULAR PROBE; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PURIFICATION; RAT; ULTRAVIOLET SPECTROPHOTOMETRY; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL PROLIFERATION; EPITHELIAL CELLS; HYPEROXIA; OXIDATIVE STRESS; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 79958263576     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-010-0248-1     Document Type: Article

References (18)

1. Altemeier WA, Sinclair SE. Hyperoxia in the intensive care unit: why more is not always better. Curr Opin Crit Care. 2007;13(1):73-8.
2. Pagano A, Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-Induced lung injury. Ann NYAcad Sci. 2003;1010:405-16.
3. Miyake Y, Kaise H, Isono K, Koseki H, Kohno K, Tanaka M. Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II cells. J Immunol. 2007;178:5001-9.
4. Mantell LL, Lee PJ. Signal transduction pathway in hyperoxia-induced lung cell death. Mol Genet Metab. 2000;71:359-70.
5. Onoue S, Yamada S, Yajima T. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD. Peptides. 2007;28:1640-50.
6. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52:269-324.
7. Howard DJ, Briggs LA, Pritsos CA. Oxidative DNA damage in mouse heart, liver, and lung tissue due to acute sidestream tobacco smoke exposure. Arch Biochem Biophys. 1998;352:293-7.
8. Dobbs LG, Gonzalez R, Williams MC. An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis. 1986;134(1):141-5.
9. Foschino Barbaro MP, Carpagnano GE, Spanevello A, Cagnazzo MG, Barnes PJ. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol. 2007;20:753-63.
10. Jiang J, Xu F, Chen J. Repair, survival and apoptosis of type II alveolar epithelial cells and the change of bcl-2/p53 in oxidative stress. Zhonghua Er Ke Za Zhi. 2008;46:74-5.
11. Fattman CL. Apoptosis in pulmonary fibrosis: too much or not enough? Antioxid Redox Signal. 2008;10:379-85.
12. Said SI. Anti-inflammatory actions of VIP in the lungs and airways. In: Said SI, editor. Pro-Inflammatory and Anti-Inflammatory Peptides. (Vol. 112 in Lung Biology in Health and Disease. C Lenfant, Exec. Editor). New York: Marcel Dekker; 1998. p. 345-61.
13. Said SI. Protection by VIP and Related Peptides against Cell Death and Tissue Injury. Ann NY Acad Sci. 2000;921:264-74.
14. Leroux P, Vaudry H, Foumier A, et al. chamcterization and localization of vasoactive intestinal peptide receptors in the rat lung. Endocrinal. 1984;114(5):1506-12.
15. Foster N, Hulme SD, Barrow PA. Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages. Cytokine. 2006;36(3-4):134-40.
16. Said SI, Dickman K. Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide. Regul Pept. 2000;93:21-9.
17. Onoue S, Ohmori Y, Endob K, Yamada S, Kimura R, Yajima T. Vasoactive intestinal peptide and pituitary adenylatecyclase activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells. Eur J Biochem. 2004;271:1757-67.
18. Koh SW, Cheng J, Dodson RM, Ku CY, Abbondandolo CJ. VIP down-regulates the inflammatory potential and promotes survival of dying (neural crest-derived) corneal endothelial cells ex vivo: necrosis to apoptosis switch and up-regulation of Bcl-2 and N-cadherin. J Neurochem. 2009;109(3):792-806.